SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
|---|
| Accounting Policies [Abstract] |
|
| SCHEDULE OF FAIR VALUE ON A RECURRING BASIS |
The
following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis:
The
fair value amounts as of March 31, 2026 are:
SCHEDULE
OF FAIR VALUE ON A RECURRING BASIS
| (in thousands) | |
Total | | |
Level 1 | | |
Level 2 | | |
Level 3 | |
| | |
| | |
| | |
| | |
| |
| Marketable securities: | |
| | | |
| | | |
| | | |
| | |
| Mutual funds | |
$ | 4,901 | | |
$ | 4,901 | | |
$ | - | | |
$ | - | |
| Total assets measured and recorded at fair value | |
$ | 4,901 | | |
$ | 4,901 | | |
$ | - | | |
$ | - | |
| | |
| | | |
| | | |
| | | |
| | |
| Liabilities: | |
| | | |
| | | |
| | | |
| | |
| Warrant liability | |
$ | 2 | | |
$ | - | | |
$ | - | | |
$ | 2 | |
| Total liabilities measured and recorded at fair value | |
$ | 2 | | |
$ | - | | |
$ | - | | |
$ | 2 | |
The
fair value amounts as of March 31, 2025 are:
| (in thousands) | |
Total | | |
Level 1 | | |
Level 2 | | |
Level 3 | |
| | |
| | |
| | |
| | |
| |
| Marketable securities: | |
| | | |
| | | |
| | | |
| | |
| Mutual funds | |
$ | 2,252 | | |
$ | 2,252 | | |
$ | - | | |
$ | - | |
| Total assets measured and recorded at fair value | |
$ | 2,252 | | |
$ | 2,252 | | |
$ | - | | |
$ | - | |
| | |
| | | |
| | | |
| | | |
| | |
| Liabilities: | |
| | | |
| | | |
| | | |
| | |
| Warrant liability | |
$ | 38 | | |
$ | - | | |
$ | - | | |
$ | 38 | |
| Total liabilities measured and recorded at fair value | |
$ | 38 | | |
$ | - | | |
$ | - | | |
$ | 38 | |
|
| SUMMARY OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED GAINS AND LOSSES |
The
following table summarizes the Company’s short-term marketable securities with unrealized gains and losses as of March 31, 2026,
aggregated by major security type:
SUMMARY
OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED GAINS AND LOSSES
| (in thousands) | |
Fair Value | | |
Unrealized Gains | |
| Mutual funds | |
$ | 4,901 | | |
$ | 39 | |
| Total short-term marketable securities | |
$ | 4,901 | | |
$ | 39 | |
The
following table summarizes the Company’s short-term marketable securities with unrealized gains and losses as of March 31, 2025,
aggregated by major security type:
| (in thousands) | |
Fair Value | | |
Unrealized Gains | |
| Mutual funds | |
$ | 2,252 | | |
$ | 39 | |
| Total short-term marketable securities | |
$ | 2,252 | | |
$ | 39 | |
|
| SCHEDULE OF ASSUMPTIONS USED IN VALUING WARRANTS |
The
significant assumptions used in valuing the warrants were as follows:
SCHEDULE
OF ASSUMPTIONS USED IN VALUING WARRANTS
| At March 31, 2026 | |
Warrants | |
| Expected term (in years) | |
| 2.25 | |
| Volatility | |
| 132.1 | % |
| Risk-free rate | |
| 3.8 | % |
| At March 31, 2025 | |
Warrants | |
| Expected term (in years) | |
| 3.25 | |
| Volatility | |
| 99.0 | % |
| Risk-free rate | |
| 3.9 | % |
|
| SCHEDULE OF KEY INPUTS DERIVATIVE |
SCHEDULE
OF KEY INPUTS DERIVATIVE
| At November 4, 2025 (issuance) | |
Derivative | |
| Maximum convertible shares | |
| 1,600,000 | |
| Share price | |
$ | 1.86 | |
| Volatility | |
| 125 | % |
| Risk-free rate | |
| 3.6 | % |
|
| SCHEDULE OF CHANGES IN FAIR VALUE OF WARRANTS AND DERIVATIVES |
The
table presented below is a summary of changes in the fair value of the Company’s Level 3 valuation for the warrants and derivatives
for the years ended March 31, 2026 and March 31, 2025 (in thousands):
SCHEDULE OF CHANGES IN FAIR VALUE OF WARRANTS AND DERIVATIVES
| | |
Warrants | | |
Derivative | |
| Balance at March 31, 2024 | |
$ | 275 | | |
$ | 1,314 | |
| Change in fair value | |
| (237 | ) | |
| (1,314 | ) |
| Balance at March 31, 2025 | |
$ | 38 | | |
$ | - | |
| Issuance | |
| - | | |
| 775 | |
| Change in fair value | |
| (36 | ) | |
| 1,395 | |
| Extinguishment | |
| - | | |
| (2,170 | ) |
| Balance at March 31, 2026 | |
$ | 2 | | |
$ | - | |
|
| SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH |
The
following table is the reconciliation of the presentation and disclosure of cash, cash equivalents, marketable securities by major security
type and restricted cash as shown on the Company’s consolidated statements of cash flows for:
SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
| (in thousands) | |
March 31,
2026 | | |
March 31,
2025 | |
| Cash and cash equivalents | |
$ | 6,740 | | |
$ | 4,665 | |
| Restricted cash | |
| 5,622 | | |
| 231 | |
| Total cash, cash equivalents and restricted cash | |
$ | 12,362 | | |
$ | 4,896 | |
| Marketable securities: | |
| | | |
| | |
| Mutual funds | |
| 4,901 | | |
| 2,252 | |
| Total marketable securities | |
$ | 4,901 | | |
$ | 2,252 | |
| | |
| | | |
| | |
| Total cash, cash equivalents, marketable securities and restricted cash | |
$ | 17,263 | | |
$ | 7,148 | |
|
| SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE OF ASSETS |
Property
and equipment are stated at cost less accumulated depreciation and accumulated amortization. Depreciation and amortization are calculated
using the straight-line method over the estimated useful life of the assets as follows:
SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE OF ASSETS
| Computer
equipment |
Three
years |
| Furniture
and fixtures |
Five
years |
| Clinical
and medical equipment |
Three3/Five
years |
| Equipment
deployable as part of a service offering |
Five
years |
| Leasehold
improvements |
Shorter
of term of lease or estimated useful life of the asset |
|
| SCHEDULE OF FUTURE EXPECTED AMORTIZATION EXPENSE |
The
expected amortization expense for the next five years and thereafter is as follows for the year ended March 31 (in thousands):
SCHEDULE OF FUTURE EXPECTED AMORTIZATION EXPENSE
| | |
| | |
| 2027 | |
$ | 205 | |
| 2028 | |
| 205 | |
| 2029 | |
| 205 | |
| 2030 | |
| 205 | |
| 2031 | |
| 198 | |
| Total | |
$ | 1,018 | |
|